These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23220324)

  • 1. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
    Kriegel C; Attarwala H; Amiji M
    Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
    Bhavsar MD; Amiji MM
    J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.
    Bhavsar MD; Amiji MM
    Gene Ther; 2008 Sep; 15(17):1200-9. PubMed ID: 18418416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.
    Bhavsar MD; Amiji MM
    AAPS PharmSciTech; 2008; 9(1):288-94. PubMed ID: 18446494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.
    Kriegel C; Amiji M
    J Control Release; 2011 Feb; 150(1):77-86. PubMed ID: 20959130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.
    Xu J; Ganesh S; Amiji M
    Int J Pharm; 2012 May; 427(1):21-34. PubMed ID: 21621597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
    Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
    Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.
    Attarwala HZ; Suri K; Amiji MM
    Bioelectricity; 2020 Jun; 2(2):167-174. PubMed ID: 34471844
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral nucleic acid therapy using multicompartmental delivery systems.
    Attarwala H; Han M; Kim J; Amiji M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28544521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
    Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
    Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of proteins by biodegradable nanoparticles.
    Bakhru SH; Furtado S; Morello AP; Mathiowitz E
    Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral drug delivery systems using chemical conjugates or physical complexes.
    Al-Hilal TA; Alam F; Byun Y
    Adv Drug Deliv Rev; 2013 Jun; 65(6):845-64. PubMed ID: 23220326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
    Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
    J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intestinal uptake of particles and the implications for drug and antigen delivery.
    O'Hagan DT
    J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):477-82. PubMed ID: 8982819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in vitro investigations.
    Guo J; O'Mahony AM; Cheng WP; O'Driscoll CM
    Int J Pharm; 2013 Apr; 447(1-2):150-7. PubMed ID: 23467082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
    Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
    Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New amphiphilic carriers forming pH-sensitive nanoparticles for nucleic acid delivery.
    Xu R; Wang XL; Lu ZR
    Langmuir; 2010 Sep; 26(17):13874-82. PubMed ID: 20672851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.